| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070523A1 Modulators of chemokine receptor activity |
| 09/12/2002 | WO2002070514A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | WO2002070502A1 Dimeric isoflavones |
| 09/12/2002 | WO2002070500A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 09/12/2002 | WO2002070496A1 Nitric oxide donors based on metallic centres |
| 09/12/2002 | WO2002070485A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/12/2002 | WO2002070484A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 09/12/2002 | WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | WO2002070468A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 09/12/2002 | WO2002070459A1 Novel amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070009A1 Preventives/remedies for thickened scar, keloid or chronic arthritic diseases |
| 09/12/2002 | WO2002070007A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | WO2002069984A2 Use of hyaluronic acid uronides for the treatment of inflammatory processes |
| 09/12/2002 | WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/12/2002 | WO2002069968A1 New use |
| 09/12/2002 | WO2002069961A1 Il-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
| 09/12/2002 | WO2002069960A2 Use of mek inhibitors for treating inflammation and virus induced hemorrhagic shock |
| 09/12/2002 | WO2002069952A1 Antiinflammatory agents containing novel compounds or derivatives thereof |
| 09/12/2002 | WO2002069945A2 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
| 09/12/2002 | WO2002069944A2 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists |
| 09/12/2002 | WO2002069930A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | WO2002069926A1 Cosmetic formulations containing flavonoid derivatives |
| 09/12/2002 | WO2002069905A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 09/12/2002 | WO2002069904A2 Cd2 antagonists for treatment of autoimmune or inflammatory disease |
| 09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
| 09/12/2002 | WO2002069883A2 Cathecin derivatives as leukocyte elastase inhibitors for treating inflammatory disorders |
| 09/12/2002 | WO2002057409A3 Antisense modulation of src-2 expression |
| 09/12/2002 | WO2002053175A3 Use of botulinum toxin for treatment of articular pathologies |
| 09/12/2002 | WO2002050030A3 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases |
| 09/12/2002 | WO2002044187A3 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 09/12/2002 | WO2002028862A3 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 09/12/2002 | WO2002028859A3 Condensed pyridoindole derivatives |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2002012346A3 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 09/12/2002 | WO2002002096A3 Oral compositions comprising host-response modulating agent |
| 09/12/2002 | WO2001089520A3 Dehydroascorbic acid formulations and uses thereof |
| 09/12/2002 | WO2001047562A3 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 09/12/2002 | WO2001041794A3 Activated amylase |
| 09/12/2002 | WO2001041768A9 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 09/12/2002 | WO2001041753A3 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 09/12/2002 | WO2001015694A9 Extended duration light activated cancer therapy |
| 09/12/2002 | WO2001012210A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 09/12/2002 | US20020128510 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines |
| 09/12/2002 | US20020128483 Sulfonamide-containing indole compounds |
| 09/12/2002 | US20020128480 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
| 09/12/2002 | US20020128471 Useful for treating cellular hyperproliferation |
| 09/12/2002 | US20020128447 Pharmaceutical composition containing IL-10 |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases |
| 09/12/2002 | US20020128317 Administering diacerein or rhein to treat inflammatory and autoimmune conditions characterized by an increased IL-1 and or TNF alpha level |
| 09/12/2002 | US20020128310 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammtory formulation |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128294 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 09/12/2002 | US20020128288 Useful in the treatment of chronic and acute pain. |
| 09/12/2002 | US20020128278 Inhibit some of the ill effects caused by diabetes or by aging; preventing premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food |
| 09/12/2002 | US20020128271 N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 09/12/2002 | US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone |
| 09/12/2002 | US20020128265 CRF receptor antagonists and methods relating thereto |
| 09/12/2002 | US20020128230 Neutrophil function inhibitors |
| 09/12/2002 | US20020128225 Methods and products related to pulmonary delivery of polysaccharides |
| 09/12/2002 | US20020128217 Therapeutic use of cis-element decoys in vivo |
| 09/12/2002 | US20020128216 Antisense oligonucleotides and peptide nucleic acids for treating asthma or an eosinophilic syndrome |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127648 Novel human C5a-like receptor |
| 09/12/2002 | US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/12/2002 | US20020127227 Antagonist monoclonal antibodies (mAb) that bind to the RHAMM (receptor for hyaluronic acid mediated motility) receptor; useful for preventing proliferative disease states in a mammal |
| 09/12/2002 | US20020127221 Urocortin proteins and uses thereof |
| 09/12/2002 | US20020127198 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | DE10111877A1 Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate New imidazolidine derivatives, their preparation, their use and pharmaceutical compositions containing them |
| 09/12/2002 | DE10111058A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten New pharmaceutical compositions based on anticholinergics and NK¶1¶ receptor antagonists |
| 09/12/2002 | DE10110772A1 Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren New pharmaceutical compositions based on anticholinergics and PDE IV inhibitors |
| 09/12/2002 | CA2440803A1 Modulators of chemokine receptor activity |
| 09/12/2002 | CA2440642A1 Dimeric isoflavones |
| 09/12/2002 | CA2440100A1 New use |
| 09/12/2002 | CA2440038A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439939A1 Novel aminodicarboxylic acid derivatives |
| 09/12/2002 | CA2439934A1 Use of protein histidine phosphatase |
| 09/12/2002 | CA2439915A1 New pharmaceutical compositions based on anticholinergics and nk1-receptor antagonists |
| 09/12/2002 | CA2439852A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | CA2439849A1 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | CA2439691A1 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 09/12/2002 | CA2439687A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | CA2439636A1 Mouse cytokine receptor |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |